The possibility of the use of interferon-gamma in Influenza infection

Abstract

Interferon-gamma (IFN-y) is a pleiotropic lymphokine that have multiple effects on the growth and differentiation of various types of cells associated with innate immunity. IFN-y induces differentiation ofmyeloid cells, stimulates the expression of major histocompatibility complex (MHC) class II and class I antigens, it is a potent activator of macrophages which destroy antigenic molecules penetrating the cell. IFN-y is widely used for the treatment of infectious diseases, cancer, autoimmune and allergic diseases. Studies conducted in Research Institute ofInfluenza indicate that drugs IFN-y can be successfully usedfor prevention of influenza and acute respiratory infection (ARI) during the rise of incidence, as well as for the treatment - the first few days/ hours of the onset. The concomitant use of drugs as IFN-a and IFN-y on influenza and ARI can greatly improve the prophylactic and therapeutic efficacy.

Keywords

interferon / interferon gamma / flu / influenza / flu treatment / prevention of influenza

References

[1] Isaacs A., Lindermann J. Virus interference. I. The interferon. Proc. Roy Soc. Lond. B. Biol. Sci. 1957; 147: 258-67.

[2] Subramaniam P.S., Torres B.A., Johnson H.M. So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine. 2001; 15: 175-87.

[3] Frucht D.M., Fukao T., Boqdan C., Schindler H., O’shea J.J. et al. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 2001; 22: 556-60.

[4] Adams D.O. Molecular interactions in macrophage activation. Immunol. Today. 1989; 10 (2): 33-5.

[5] Munder M., Mallo M., Eichmann K., Modolell M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 1998; 187: 2103-8.

[6] Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 2001; 55: 255-81.

[7] Young H.A., Hardy K.J. Role of interferon-gamma in immune cell regulation. J. Leukoc. Biol. 1995; 58: 373-81.

[8] Bach E.A., Aguet M., Schreiber R.D. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 1997; 15: 563-91.

[9] Ершов Ф.И., Киселев О.И. Интерфероны и их индукторы (от молекул до лекарств). 2005. М.: Гэотар-Медиа; 2005.

[10] Киселев О.И., Ершов Ф.И., Деева Э.Г. Гамма-интерферон: новый цитокин в клинической практике «Ингарон». М.- СПб.: Компания «Димитрэйд График Групп»; 2007.

[11] Bot A., Bot S., Bona C.A. Protective role of gamma interferon during the recall response to influenza virus. J. Virol. 1998; 72(8): 6637-45.

[12] Bernabei P., Coccia E.M., Rigamonti L., Bosticardo M., Forni G., Pestka S. et al. Interferongamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J. Leukoc. Biol. 2001; 70: 950-60.

[13] Федорченко С.В. Комбинированная терапия рекомбинантным α2- и γ-интерфероном больных с хронической дельта-вирусной инфекцией. Клиническая медицина. 1996; 2: 35-7.

[14] Musch E., Hogemann B., Gerritzen A., Fischer H.P., Wiese M., Kruis W. et al. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Hepatogastroenterology. 1998; 45 (24): 2282-94.

[15] Сологуб Т.В., Токин И.И., Цветков В.В., Деева Э.Г. Возможности использования интерферона-гамма в комплексной терапии больных хроническим гепатитом С. Инфекционные болезни. 2013; 11 (2): 74-80.

[16] Jia Y.T., Wei L., Jiang D., Cong X., Fei R. The direct antiviral effect of interferon-gamma on hepatitis C virus replicon. Zhonghua Gan Zang Bing Za Zhi. 2006; 14 (1): 7-10.

[17] Иола А.И. Сравнительная клинико-лабораторная и эпидемиологическая характеристика ВИЧ/СПИД инфекции, ассоциированной с туберкулезом в Нигерии и России: Дисс. ...д-ра мед. наук. М.; 2006.

[18] Сологуб Т.В., Иванов А.К., Йола И. Использование интерферонов и их индукторов в терапии ВИЧ-инфекции. Конгресс инфекционистов. Вашингтон; 2005.

[19] Callard R., Gearing A. The cytokine facts book. In: IFN-gamma. London: Academic Press; 1994: 157-62.

[20] Tomoda T., Morita H., Kurashige T., Maassab H.F. Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferongamma production and local IgA response. Vaccine. 1995; 13 (2): 185-90.

[21] Gallin I.J., Farber J.M., Holland S.M., Nutman T.B. Interferon-γ in the management of infection diseases. Ann. Intern. Med. 1995; 123 (3): 216-24.

RIGHTS & PERMISSIONS

Eco-vector